Biotech/Biomedical
News Category
Instinct Bio Partners With INVITRX to Bring GENREVER to U.S. and Boost Indonesia Regenerative Medicine
Instinct Bio announced a strategic collaboration with INVITRX to license its GENREVER cosmetic brand for U.S. manufacture and sale, and to supply exos...
Alexandre B. de Moura, MD, and Timothy T. Roberts, MD, Named 2026 Castle Connolly Top Doctors
Two orthopaedic spine surgeons at New York Spine Institute have been recognized as Castle Connolly Top Doctors, an honor awarded to only 7% of U.S. ph...
BRAIN Biotech AG Appoints Dr. Sven K. Weber as New CEO, Succeeding Adriaan Moelker
Dr. Sven K. Weber will become CEO of BRAIN Biotech AG on October 1, 2026, bringing extensive experience from BASF's global enzyme business to drive gr...
ZEAL Network SE Invites to Earnings Call for Half-Year Report 2026
ZEAL Network SE, the leading German online lottery broker, has scheduled an earnings call on August 5, 2026, to discuss its half-year results, offerin...
Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with Cell-Free Gelrin C
Regentis Biomaterials is advancing its Gelrin C hydrogel as a scalable, single-procedure treatment for knee cartilage defects, aiming to address the $...
VERAXA Biotech Expands Patent Portfolio to Bolster Next-Generation Cancer Therapies
VERAXA Biotech's expanded patent portfolio, including new filings for BiTAC-TCE and BiTAC-ADC platforms, strengthens its position in developing safer,...
MindBio Therapeutics Delivers Edge AI Kiosk Prototypes for Rapid Impairment Screening in Safety-Sensitive Industries
MindBio Therapeutics has completed its first Edge AI kiosk prototypes for voice-based impairment detection, targeting workplace safety in mining, avia...
NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Data Analytics on S&P 500 Company's Platform
NeuroThera Labs announces internal validation of a proprietary quantum sampling workflow that enables continuous clinical data to be represented and a...
American Fusion Inc. Begins Texatron(TM) Fusion Engine Testing Program at Texas Tech
American Fusion has initiated testing of its Texatron(TM) Fusion Engine at Texas Tech University, marking a critical step toward validating the platfo...
Datavault AI Expands DataMEDS Licensing Agreement Into Commercial Healthcare, Targeting Patient-Controlled Data Models
Datavault AI broadens its DataMEDS licensing deal to commercial healthcare, enabling patient-controlled data access and monetization across pharmacy, ...
Why the Fed Vote Tally Matters More Than the Decision
The article explains that the distribution of votes among FOMC members is a more revealing indicator of future monetary policy than the rate decision ...
VERAXA Biotech Appoints Dr. Christoph Erkel as Chief Scientific Officer to Drive BiTAC(R) Cancer Therapy Platform Toward Clinical Development
VERAXA Biotech (NASDAQ: VRXA) names antibody therapeutics expert Dr. Christoph Erkel as CSO to advance its proprietary BiTAC(R) platform and prepare l...
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms Through 2047
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, ex...
American Fusion Appoints Chief Revenue Officer as Texatron Fusion Engine Advances Toward Commercialization
American Fusion Inc. has appointed Alec Rossa as Chief Revenue Officer to lead commercialization efforts, while the Texatron Fusion Engine progresses ...
Nearly 23 Million U.S. Adults With High Blood Pressure May Need Medication Under New Guideline
A new study finds that 28% of U.S. adults with high blood pressure are newly eligible for medication under the 2025 AHA/ACC guideline, with over 9 mil...
Dr. Edward H. Davidson Named 2026 Castle Connolly Top Doctor for Plastic Surgery
Dr. Edward H. Davidson, a board-certified plastic surgeon at Palm Beach Plastic Surgery Institute, has been honored as a 2026 Castle Connolly Top Doct...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology
Greenland Mines (GRML) received a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and...
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial While Commercial Product unbuzzd Generates Revenue
Quantum BioPharma's executive outlines the company's dual strategy of advancing its lead MS drug candidate Lucid-MS into human trials and commercializ...
VERAXA Biotech Shareholders Overwhelmingly Approve Corporate Governance and Financing Measures
VERAXA Biotech shareholders approved proposals to enhance corporate governance and financing flexibility, supporting the company's long-term growth st...
NowMedia Television Networks and Dr. Nathan S. Bryan Launch 'Your Optimal Health' Program
NowMedia Television Networks and nitric oxide expert Dr. Nathan S. Bryan debut a science-based health program to educate audiences on cardiovascular h...
Regentis Biomaterials Builds Momentum as GelrinC Advances Toward Clinical and Regulatory Milestones
Regentis Biomaterials is advancing its cell-free hydrogel implant GelrinC through pivotal clinical and regulatory stages, with U.S. enrollment and Eur...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases
Greenland Mines Ltd. has been granted a Canadian patent for its Klotho-based gene therapy technology, covering 42 claims for treating neurodegenerativ...
Standardized Language for Functional Safety Gains Traction in Semiconductor Industry
The push for a common functional safety language, supported by TSMC, aims to streamline semiconductor design and deployment across safety-critical app...
Silver Prices Edge Higher Amid Geopolitical Uncertainty
Silver prices rose slightly as investor sentiment shifted toward precious metals due to growing geopolitical tensions, with implications for mining co...
Researchers to Investigate How Autoantibodies Influence Cancer Risk and Immune Response
A new study aims to explore why some individuals with cancer risk factors remain disease-free while others without risk factors develop cancer, focusi...
Gaxos.ai Outlines Post-Divestiture Strategy Focused on AI and Health Businesses
Gaxos.ai announced its strategic shift after selling gaming assets, concentrating on expanding AI applications through Gaxos Labs and personalized hea...
NextPlat Corp. Reports Mid-Year Progress Toward Profitability
NextPlat Corp. announced mid-year progress in its strategic turnaround, citing improved operating performance, record gross margins, and a strong cash...
NanoViricides Awaits Regulatory Decision on Ebola Trial for NV-387 Oral Gummies
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
Lantern Pharma Receives EMA Clearance for LP-184 Bladder Cancer Trial in Europe
Lantern Pharma announced EMA clearance for a Phase 1b/2 trial of LP-184 in advanced bladder cancer, advancing its AI-driven precision oncology strateg...
Nightfood Holdings' TechForce Robotics Featured in AINewsWire Editorial on Connected Robotics
Nightfood Holdings Inc. (OTCQB: NGTF), operating as TechForce Robotics, is highlighted in an AINewsWire editorial for its Robotic Connective Network a...
Earth Science Tech Builds Vertically Integrated Healthcare Platform for Dilution-Free Growth
Earth Science Tech Inc. leverages its compounding pharmacy subsidiaries and telemedicine to create a self-sustaining healthcare ecosystem that reduces...
LataMed AI Partners with Caracas Schools to Launch Telemedicine Services for Students and Families
LataMed AI Corp. has signed agreements with two Caracas schools to develop school-based telemedicine programs, expanding access to digital healthcare ...
NeuroOne Reports Real-World Evidence Supporting OneRF® Ablation System as a Paradigm Shift in Epilepsy Treatment
Physicians at Mayo Clinic Florida report that NeuroOne's OneRF® Brain Ablation System, used with SEEG electrodes, significantly reduces seizure freque...
From Brooklyn Roots to National Retail: Mitch Gould's Three-Decade Journey Reshaping Brand Market Entry
Mitch Gould's career, rooted in family entrepreneurship, has evolved into a model that simplifies U.S. market entry for brands, impacting major retail...
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
Renaissance BioScience is developing a yeast-based RNAi biopesticide for wireworms, funded by Genome BC, which could expand RNAi technology to soil-dw...
Flow Cytometry Diagnostics Market Set to Reach USD 3.5 Billion by 2036 Driven by MRD Testing and Multiparametric Analysis
The global flow cytometry diagnostics market is projected to grow from USD 1.5 billion in 2026 to USD 3.5 billion by 2036, driven by rising demand for...
High-Pressure Glass Autoclaves Market to Reach USD 355 Million by 2036, Driven by Research Visibility Needs
The global high-pressure glass autoclaves market is projected to grow from USD 162 million in 2026 to USD 355 million by 2036 at an 8.2% CAGR, fueled ...
David Ferrera Urges Greater Focus on Translational Discipline in Medical Device Innovation
David Ferrera, CEO of RC Medical, highlights the critical gap between promising medical device ideas and successful patient outcomes, advocating for a...
GeoVax Reports Q2 2026 Financial Results and Advances GEO-MVA Toward Pivotal Study
GeoVax Labs reported a narrower net loss for Q2 2026 and provided updates on its lead programs, including preparations for a pivotal immunobridging st...
VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration
VERAXA Biotech advances its bispecific ADC program VXA-222 after OmniAb completes discovery work, moving toward next-phase development for precision s...
Quantum BioPharma Outlines Lucid-MS Development Strategy and Commercial Growth Plans in BioMedWire Podcast
Quantum BioPharma's executive details the advancement of its lead multiple sclerosis drug candidate Lucid-MS toward Phase 2 trials and the commercial ...
Onco-Innovations Advances Lead Oncology Candidate ONC010 Toward Clinical Studies
Onco-Innovations Limited is progressing its lead PNKP inhibitor ONC010 through manufacturing scale-up, partnerships, and regulatory planning to enable...
Regentis Biomaterials Targets $3B Cartilage Repair Market with GelrinC
Regentis Biomaterials is advancing its GelrinC platform to address the large unmet need in cartilage repair, leveraging a regenerative approach that f...
Earth Science Tech Reports Fiscal 2026 Growth, Advances Integrated Telemedicine-to-Fulfillment Platform
Earth Science Tech Inc. reported fiscal 2026 results with revenue up 8% to $35.7 million, highlighting its progress in building a vertically integrate...
Culturally Tailored Navajo Meals Reduce Heart Failure Hospitalizations in Landmark Trial
A randomized clinical trial found that adults with heart failure in the Navajo Nation who received eight weeks of medically tailored meals incorporati...
Gold Extends Decline as Traders Await Fed Meeting, Impacting Miners Like Numa Numa Resources
Gold prices continue to fall as expectations of a Federal Reserve interest rate hike due to energy-fueled inflation pressure precious metals, potentia...
Experimental Immunotherapy Shows Promise for Aggressive Pediatric Brain Cancer
A study in Nature Medicine finds that experimental immunotherapy may offer new hope for children with deadly brain and spinal cord tumors, while other...
American Fusion Presents Texatron Technology at APS Conference, Highlighting GEM Unification Theory
American Fusion Inc. showcased its Texatron Fusion Engine and GEM Unification Theory at the APS Particle Physics Conference, drawing strong audience e...